JANX Operating Margin
-598.15%TTM
Period ending:
JANX FY Operating Margin%
189.20%-1765.87%
2019-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.
JANX operating margin history
Operating income as a percentage of revenue. The available annual fiscal periods series contains 7 observations from Dec 31, 2019 to Dec 31, 2025.
| Period ending | Operating Margin |
|---|---|
| -1,576.67% | |
| -933.5757% | |
| -902.8702% | |
| -779.0409% | |
| -905.3891% | |
| 0% | |
| 0% |
Compare operating margin
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) operating margin
- Bridgebio Pharma Inc (BBIO) operating margin
- Brightspring Health Services Inc (BTSG) operating margin
- Madrigal Pharmaceuticals Inc (MDGL) operating margin
- Ensign Group Inc (ENSG) operating margin
- Glaukos Corp (GKOS) operating margin
- Krystal Biotech Inc (KRYS) operating margin
- Twist Bioscience Corp (TWST) operating margin
Compare all covered stocks by operating margin →
All JANX financial metrics · JANX stock overview · How to interpret financial metrics
